Staedtisches Klinikum Dessau

This site has a strong focus on cancer research, with trials centered on breast cancer, colorectal cancer, lymphoma, multiple myeloma, melanoma, and endometrial cancer. The studies are designed to test new treatment strategies, compare standard approaches, and improve outcomes for people with early-stage, advanced, or recurrent disease.

• Breast cancer studies exploring better endocrine, targeted, and antibody-based treatments
• Colorectal cancer trials evaluating new combinations and treatment timing around surgery
• Lymphoma and myeloma research focused on improving response and long-term disease control
• Melanoma and endometrial cancer trials assessing newer immunotherapy and targeted options

The Department of Radiation Therapy supports a broad oncology portfolio that aims to refine treatment effectiveness while reducing disease recurrence and treatment-related burden.

Much of the clinical research at this German hospital is devoted to breast cancer, especially hormone receptor-positive, HER2-negative, and HER2-positive disease. These trials examine whether newer targeted medicines and endocrine-based combinations can improve survival, delay progression, and lower the risk of recurrence.

• Early breast cancer studies aimed at preventing relapse after initial treatment
• Advanced breast cancer trials testing new combinations for disease control
• Research in ESR1-mutated and PIK3CA-mutant disease
• Comparisons of emerging therapies with established endocrine-based care

These studies reflect a major effort to personalize treatment for different breast cancer subtypes and to improve long-term outcomes for patients.

Research in digestive system diseases includes trials for metastatic colorectal cancer and colon cancer. The main goal is to find better ways to treat disease before or after surgery and to evaluate whether new treatment combinations can improve effectiveness compared with current standard care.

• Metastatic colorectal cancer studies comparing different drug combinations
• Colon cancer research focused on treatment before surgery
• Trials assessing whether added therapy after local treatment improves outcomes

At Staedtisches Klinikum Dessau, this area of research is centered on making treatment more effective across different stages of colorectal disease.

The site also participates in trials for hematologic malignancies, including acute lymphoblastic leukemia, diffuse large B-cell lymphoma, Hodgkin lymphoma, and multiple myeloma. These studies aim to improve survival, deepen treatment response, and better define maintenance or follow-up strategies.

• Leukemia research for newly diagnosed Ph+ ALL
• Lymphoma trials comparing new frontline treatment approaches
• Multiple myeloma studies focused on stronger and more durable responses
• Work on reducing toxicity while maintaining treatment effectiveness

This field highlights a clear interest in advancing care for blood cancers through more precise and better-tolerated therapies.

Several trials address immune system diseases and related inflammatory conditions, including systemic lupus erythematosus and hidradenitis suppurativa. The research is mainly aimed at understanding long-term safety, symptom control, and the potential of newer immune-targeted treatments.

• Studies in systemic lupus erythematosus evaluating long-term treatment safety
• Trials in hidradenitis suppurativa examining new options for chronic inflammation
• Research focused on balancing effectiveness with tolerability

These studies broaden the site’s research portfolio beyond oncology and support better care for chronic immune-mediated disease.

Clinical studies in skin and connective tissue diseases include research on atopic dermatitis and hidradenitis suppurativa. The purpose is to test new therapies and assess how well they control persistent symptoms such as inflammation, discomfort, and skin lesions.

• Atopic dermatitis trials comparing active treatment with placebo
• Hidradenitis suppurativa research focused on long-term disease control
• Studies designed to improve quality of life in chronic skin disease

These investigations show an interest in both symptom relief and longer-term management of difficult-to-treat dermatologic conditions.

The site’s portfolio also includes eye disease research, particularly uveal melanoma, along with studies linked to immune system processes. These trials are designed to evaluate whether new approaches can better preserve vision, control tumor growth, or support more effective disease management.

• Uveal melanoma studies around treatment before surgery or radiation
• Research aimed at preventing vision loss and avoiding eye removal
• Trials exploring improved control of rare ocular cancers

At the Klinik & Medizinisches Versorgungszentrum für Strahlentherapie, this reflects a broader commitment to specialized cancer care with attention to function and quality of life.